Healthcare Equipment and Supplies
Company Overview of TransMedics, Inc.
TransMedics, Inc. develops living organ transplant systems. It offers TransMedics Organ Care System, a portable warm blood perfusion system, designed to maintain organs in a warm and functioning state outside the human body during transport from organ donor to recipient. The company’s products are used in heart, lung, liver, and kidney transplants. It serves hospitals and clinicians, patients and families, donor organizations, and insurers and payors. The company markets and sells its products in the United States, the European Union, Asia, and the Middle East. TransMedics was founded in 1998 and is headquartered in Andover, Massachusetts.
200 Minuteman Road
Andover, MA 01810
Founded in 1998
Key Executives for TransMedics, Inc.
Vice President of Operations
Director of IP & In-house Counsel
Director of Clinical Affairs and Trials
Compensation as of Fiscal Year 2014.
TransMedics, Inc. Key Developments
TransMedics, Inc. Announces Final Results of The PROCEED II Heart FDA Pivotal Trial at ISHLT
Apr 14 14
TransMedics, Inc. announced that the PROCEED II heart transplant Food and Drug Administration pivotal trial results using the Organ Care System - Heart platform were announced on Saturday, April 12, 2014 at the International Society for Heart and Lung Transplantation 34th Annual Meeting and Scientific Sessions in San Diego, Calif. The OCS Heart PROCEED II FDA pivotal trial met its success criteria for both the primary effectiveness and safety endpoints by demonstrating that the OCS is as safe and effective as the current standard of care (SOC) in preserving standard donor hearts for transplantation. These results were achieved despite the OCS arm having significantly longer total cross clamp time as compared to SOC. In addition, the data from PROCEED II Trial demonstrated that circulating lactate level of the OCS perfusion could be a useful parameter to evaluate donor hearts status ex-vivo.
TransMedics, Inc. Appoints Jeffrey E. Young as Chief Financial Officer and Treasurer
Nov 8 13
TransMedics, Inc. announced that Jeffrey E. Young was appointed to the position of Chief Financial Officer and Treasurer, effective August 2013. Mr. Young responsible for the company's finance, accounting, and treasury functions and reports directly to Waleed Hassanein, M.D., President and Chief Executive Officer of the company. During his career, Mr. Young has held a variety of senior executive roles in the life sciences industry. From 2008 to 2013, Mr. Young served in a number of senior executive roles at Lantheus Medical Imaging, including Chief Financial Officer from 2012 to 2013. Prior to his time with Lantheus, Mr. Young spent three years at Critical Therapeutics, Inc. Prior to 2005, he served in a number of roles at PerkinElmer, Inc.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|